Envigo Facilities Earn AAALAC Accreditation
News Jul 20, 2016
Envigo has announced that its breeding facilities in Bresso, Italy and Wyton, UK have been granted full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. This news follows the accreditation of Envigo’s Horst, Netherlands facility earlier this year and demonstrates continued progress towards the company’s goal to have all sites accredited by AAALAC. To support these achievements, Envigo has made targeted investments in people, process and facilities that will help to ensure the quality of Envigo research models.
Recent developments at the Bresso site in Italy illustrate the quality improvement programs now in place throughout Envigo breeding facilities. The almost 3,000 m² ISO:9001-2008 certified site consists of a contract breeding services area, an assisted reproductive technologies laboratory, and a health monitoring laboratory for microbiology, immunology and molecular biology testing. The facility also has quarantine and embryo transfer areas and a research space for customers. The contract breeding services area has recently been expanded and new laboratory management software has been installed.
Improvements have been made to the health monitoring laboratory which now offers fully validated PCR and immunology tests with the data managed through a recently validated upgraded LIMS system. Dr. Paul Brooker, President of Contract Research and Research and Models Services in Europe commented: “The AAALAC accreditation of Wyton and Bresso is great news and demonstrates the high standards we set for animal welfare and quality at Envigo. This is the third accreditation for our European breeding facilities in four months and is testimony to the efforts and commitment of our professional staff, which has now been validated by AAALAC, a great honor for us all.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE